Skip to content

Continuous noninvasive blood pressure clinical trials

Continuous noninvasive blood pressure clinical trials

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300079037
Enrollment
Unknown
Registered
2023-12-25
Start date
2024-01-01
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Gold Standard:Patient monitor, model: ePM 12M
Index test:EP30 vital sign monitor

Sponsors

Shenzhen People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 99 Years

Inclusion criteria

Inclusion criteria: (1) Patients who need to be monitored for at least 24 hours for invasive blood pressure (puncture site is radial, brachial, or ulnar artery); (2) children or adults over 12 years of age, including male and female; (3) subjects' blood pressure was normal, hypertension or hypotension;

Exclusion criteria

Exclusion criteria: (1) Subject perfusion index (PI) < 0.3; (2) the subject has persistent agitation or tremors (e.g., Parkinson's disease); (3) pregnancy; (4) Patients with frequent non-rhythmic arrhythmias (such as atrial fibrillation); (5) Participants in other clinical trials; (6) Subjects deemed unsuitable for participation by the researcher.

Design outcomes

Primary

MeasureTime frame
accuracy;stability;changes;

Countries

China

Contacts

Public ContactLiu Xueyan

Shenzhen People's Hospital

1736574753@qq.com+86 180 2538 8894

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026